# Effect of Rapid Steroid Withdrawal on Subclinical Markers of Rejection

> **NCT00133172** · PHASE4 · TERMINATED · sponsor: **Astellas Pharma Inc** · enrollment: 85 (actual)

## Conditions studied

- Kidney Transplantation

## Interventions

- **DRUG:** Tacrolimus
- **DRUG:** mycophenolate mofetil
- **DRUG:** Prednisone

## Key facts

- **NCT ID:** NCT00133172
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-07
- **Primary completion:** 2007-03
- **Final completion:** 2007-03
- **Target enrollment:** 85 (ACTUAL)
- **Why stopped:** Varience of supply chain from that required by protocol
- **Last updated:** 2014-09-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00133172

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00133172, "Effect of Rapid Steroid Withdrawal on Subclinical Markers of Rejection". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00133172. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*